Table 6 |
||
|
Comparison of microarray analysis between two studies |
||
|
Gene |
Fold change in John-Aryankalayil et al |
Fold change in our study |
|
|
||
|
Significantly regulated in current study (p < 0.05) |
||
|
|
||
|
SILV (silver homolog) |
2.2 |
2.3 |
|
CD31 (PECAM1) |
2.1 |
2.2 |
|
C5orf13 |
2.5 |
2.2 |
|
RBP1 |
3.6 |
2.0 |
|
Von Willebrand factor |
2.5 |
2.0 |
|
RAB31 |
2.0 |
1.7 |
|
Clathrin (CLTB) |
2.4 |
1.7 |
|
DAB2 |
2.1 |
1.5 |
|
S100 A9 (calgranulin B) |
2.2 |
1.4 |
|
MAP 17 |
2.4 |
1.4 |
|
MIP-4 |
4.9 |
1.4 |
|
ECM1 |
3.2 |
1.3 |
|
COMP |
2.0 |
1.3 |
|
versican |
3.3 |
1.2 |
|
TRAP100 |
5.0 |
1.2 |
|
CD32 receptor |
2.9 |
1.2 |
|
mRNA, clone AL050154 |
2.8 |
1.1 |
|
CLIC2 |
0.5 |
1.1 |
|
Prostaglandin F2alpha receptor |
3.2 |
1.1 |
|
|
||
|
Not significantly regulated in current study (p > 0.05) |
||
|
|
||
|
NDRG4 |
3.1 |
1.1 |
|
Carbonic anhydrase CA1 |
0.5 |
1.1 |
|
ABCG1 |
2.3 |
1.1 |
|
ADPRTL2 |
2.3 |
1.1 |
|
Casein kinase II |
2.5 |
1.0 |
|
Collagen III |
4.1 |
1.0 |
|
Fibronectin |
8.5 |
1.0 |
|
LZTR1 |
2.2 |
1.0 |
|
Collagen VI |
2.1 |
1.0 |
|
Myosin heavy chain II |
3.1 |
0.9 |
|
FUBP |
0.5 |
0.9 |
|
Ephrin-A1 |
0.5 |
0.9 |
|
Per1 |
0.5 |
0.9 |
|
Lipocalin 2 |
2.4 |
0.9 |
|
|
||
|
Tong et al. BMC Medical Genomics 2009 2:14 doi:10.1186/1755-8794-2-14 |
||